Eliem Therapeutics, Inc. Profile Avatar - Palmy Investing

Eliem Therapeutics, Inc.

Eliem Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy, and other disorders of the peripheral and central ner…

Biotechnology
US, Redmond [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Eliem Therapeutics, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Eliem Therapeutics, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Eliem Therapeutics, Inc..

End of ELYM's Analysis
CIK: 1768446 CUSIP: 28658R106 ISIN: US28658R1068 LEI: - UEI: -
Secondary Listings
ELYM has no secondary listings inside our databases.